Abstract
Transgenic mice expressing mutant (P301L) human tau develop neurofibrillary tangles, amyotrophy and progressive motor disturbance. We present ultrastructural features of neuronal degeneration in this model that suggests involvement of both neurofibrillary and autophagic processes in neurodegeneration. Neurons undergoing neurofibrillary degeneration contain tau-immunoreactive, 15–20 nm-wide straight or wavy filaments with no periodic twists. Tau filaments were found in two types of affected neurons. One type resembled neurons with neurofibrillary tangles (NFT) that were filled with numerous filaments that displaced sparse cytoplasmic organelles to the periphery. Microtubules were almost completely absent. The nucleus remained centrally located, but showed lobulations due to deep infoldings. The other type resembled ballooned neurons seen in some human tauopathies. The nucleus was peripherally placed, but normal appearing. The cytoplasmic organelles were dispersed throughout the swollen perikarya, the Golgi complex was fragmented and duplicated, while mitochondria and other organelles appeared normal. Tau filaments similar to those in NFT were sparse and not tightly packed. Microtubules were also sparse. Many autophagic vacuoles were present in these cells. Heterogeneous appearing axonal swellings resembling spheroids in human tauopathies were present in gray and white matter. Unlike normal appearing axons, axonal spheroids were filled with tau-immunoreactive filaments and autophagic vacuoles, in addition to normal appearing neurofilaments and microtubules. These P301L transgenic mice exhibit many features common to human tauopathies, making them a valuable model to study the pathogenesis of these uncommon disorders.
Similar content being viewed by others
References
ALLEN, B., INGRAM, E., TAKAO, M., SMITH, M. J., JAKES, R., VIRDEE, K., YOSHIDA, H., HOLZER, M., CRAXTON, M., EMSON, P. C., ATZORI, C., MIGHELI, A., CROWTHER, R. A., GHETTI, B., SPILLANTINI, M. G. & GOEDERT, M. (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. Journal of Neuroscience 22, 9340–9351.
ANGLADE, P., VYAS, S., JAVOY-AGID, F., HERRERO, M. T., MICHEL, P. P., MARQUEZ, J., MOUATTPRIGENT, A., RUBERG, M., HIRCH, E. C. & AGID, Y. (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histology and Histopathology 12, 25–31.
ARIMA, K., UESUGI, H., FUJITA, I., SAKURAI, Y., OYANAGI, S., ANDOH, S., IZUMIYAMA, Y. & INOSE, T. (1994) Corticonigral degeneration with neuronal achromasia presenting with primary progressive aphasia: Ultrastructural and immunocytochemical studies. Journal of the Neurological Sciences 127, 186–197.
BIRD, T. D., NOCHLIN, D., POORKAJ, P., CHERRIER, M., KAYE, J., PAYAMI, H., PESKIND, E., LAMPE, T. H., NEMENS, E., BOYER, P. J. & SCHELLENBERG, G. D. (1999) A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain 122, 741–756.
BRION, J.-P., TREMP, G. & OOTAVE, J.-N. (1999) Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. American Journal of Pathology 154, 255–270.
CATALDO, A. M., HAMILTON, D. J., BARNETT, J. L., PASKEVICH, P. A. & NIXON, R. A. (1996) Properties of the endosomal-lysosomal system in the human central nervous system: Disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. Journal of Neuroscience 16, 186–199.
CLARK, L. N., POORKAJ, P., WSZOLEK, Z., GESCHWIND, D. H., NASERDDINE, Z. S., MILLER, B., LI, D., PAYAMI, H., AWERT, F., MARKOPOULOU, K., ANDREADIS, A., D'SOUZA, I., LEE, V. M.-Y., REED, L., TROJANOWSKI, J. Q., ZHUKAREVA, V., BIRD, T., SCHELLENBERG, G. & WILHELMSEN, K. C. (1998) Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proceedings of the National Academy of Science USA 95, 13103–13107.
CROWE, A., KSIEZAK-REDING, H., LIU, W.-K., DICKSON, D. W. & YEN, S.-H. (1991) The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments. American Journal of Pathology 139, 1463–1470.
DELACOURTE, A. & BUEE, L. (1997) Normal and pathological tau proteins as factors for microtubule assembly. International Review of Cytology 171, 167–224.
DICKSON, D. W., LIU, W.-K., KSIEZAK-REDING, H. & YEN, S.-H. (2000) Neuropathologic and molecular considerations. In Advances in Neurology, vol. 82, Corticobasal Degeneration. (edited by LITVAN, I., GOETZ, C. G. & LANG, E.) pp. 9–27. Philadelphia: LippincottWilliams & Wilkins.
DUFF, K., KNIGHT, H., REFOLO, L. M., SANDERS, S., YU, X., PICCIANO, M., MALESTER, B., HUTTON, M., ADAMSON, J., GOEDERT, M., BURKI, K. & DAVIS, P. (2000) Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiology of Disease 7, 87–98.
DUMANCHIN, C., CAMUZAT, A., CAMPION, D., VERPILLAT, P., HANNEQUIN, D., DUBOIS, B., SAUGIER-VEBER, P., MARTIN, C., PENET, C., CHARBONNIER, F., AGID, Y., FREBOURG, T. & BRICE, A. (1998) Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Human Molecular Genetics 7, 1825–1929.
ELLISMAN, M., RANGANATHAN, R., DEERINCK, T., YOUNG, S., TERRY, R. & MIRRA, S. (1987) Neuronal fibrillar cytoskeleton and endomembrane system organization in Alzheimer's disease. In Alterations in the Neuronal Cytoskeleton in Alzheimer's Disease (edited by PERRY, G.) pp 61–73. New York: Plenum Press.
GARCIA, M. L. & CLEVELAND, D. W. (2001) Going new places using an old MAP: Tau, microtubules and human neurodegenerative diseases. Current Opinion in Cell Biology 13, 41–48.
GHADIALLY, F. N. (1997) Ultrastructural Pathology of the Cell and Matrix. Boston: Butterworth-Heinemann.
GÖTZ, J., CHEN, F., BARMETTLER, R. & NITSCH, R. M. (2001) Tau filament formation in transgenic mice expressing P301L tau. Journal of Biological Chemistry 276, 529–534.
HUTTON, M., LENDON, C. L., RIZZU, P., BAKER, M., FROELICH, S., HOULDEN, H., PICKERINGBROWN, S., CHAKROVERTY, S., ISAACS, A., GROVER, A., HACKETT, J., ADAMSON, J., LINCOLN, S., DICKSON, D., DAVIS, P., PETERSEN, R. C., STEVENS, M., DEGRAAFF, E., WAUTERS, E., VAN BAREN, J., HILLEBRAND, M., JOOSSE, M., KWON, J. M. & NOWOTNY, P. (1998) Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702–705.
IIJIMA, M., TABIRA, T., POORKAJ, P., SCHELLENBERG, G. D., TROJANOWSKI, J. Q., LEE, V. M.-Y., SCHMIDT, M. L., TAKEHASHI, K., NABIKA, T., MATSUMOTO, T., YAMASHITA, Y., YOSHIOKA, S. & ISHINO, H. (1999) A distinct familial dementia with a novel missense mutation in the tau gene. NeuroReport 10, 497–501.
ISHIHARA, T., HONG, M., ZHANG, B., NAKAGAWA, Y., LEE, M. K., TROJANOWSKI, J. Q. & LEE, V. M.-Y. (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24, 751–762.
LEE, M.-Y. V., GOEDERT, M. & TROJANOWSKI, J. Q. (2001) Neurodegenerative tauopathies. Annual Reviews of Neuroscience 24, 1121–1159.
LEE, S., PARK, D., YEN, S.-H., KSIEZAK-REDING, H., GOLDMAN, J. E. & DICKSON, D. W. (1989) A study of infantile motor neuron disease with neurofilament and ubiquitin immunocytochemistry. Neuropediatrics 20, 107–111.
LEWIS, J., MCGOWAN, E., ROCKWOOD, J., MELROSE, H., NACHARAJU, P., VAN SLEGTENHORST, M., GWINN-HARDY, K., MURPHY, M. P., BAKER, M., YU, X., DUFF, K., HARDY, J., CORRAL, A., LIN, W.-L., YEN, S.-H., DICKSON, D. W., DAVIS, P. & HUTTON, M. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nature Genetics 25, 402–405.
LIM, F., HERNANDEZ, F., LUCAS, J. J., GOMEZRAMOS, P., MORAN, M. A. & AVILA, J. (2001) FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and tau filaments in forebrain. Molecular and Cellular Neuroscience 18, 702–714.
LIN, W.-L. (1990) Immunogold localization of basal laminar heparan sulfate proteoglycan in rat brain and retinal capillaries. Brain Research Bulletin 24, 533–536.
LIN, W.-L., LEWIS, J., CORRAL, A. R., DICKSON, D. W. & HUTTON, M. (2000) Ultrastructural pathology of neurofibrillary tangles in transgenic mice carrying mutant (P301) human tau gene. Microscopy and Microanalysis 6(Suppl 2), 584–585.
LIN, W.-L., LEWIS, J., YEN, S.-H., HUTTON, M. & DICKSON, D. W. (2003) Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation. American Journal of Pathology 162, 213–218.
MASLIAH, E., SISK, A., MALLORY, M., MUCKE, L. & GAMES, D. (1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F ßamyloid precursor protein and Alzheimer's disease. Journal of Neuroscience 16, 5795–5811.
METUZALS, J., ROBITAILLE, Y., HOUGHTON, S., GAUTHIER, S. & LEBLANC, R. (1988) Paired helical filaments and the cytoplasm-nuclear interface in Alzheimer's disease. Journal of Neurocytology 17, 827–833.
MIKOL, J., BRION, S., GUICHARNAUD, L. & WAKS, O. (1980) A new case of Pick's disease. Anatomical and ultrastructural studies. Acta Neuropathologica 49, 57–61.
MURAYAMA, S., MORI, H., IHARA, Y. & TOMONAGA, M. (1990) Immunocytochemical and ultrastructural studies of Pick's disease. Annals of Neurology 27, 394–405.
OYANAGI, S. (1992) Neuropathology by Electron Microscopy. pp. 171–172. Tokyo: Igaku-Shoin (in Japanese).
POORKAJ, P., BIRD, T. D., WIJSMAN, E., NEMENS, E., GARRUTO, R. M., ANDERSON, L., ANDREADIS, A., WEIDERHOLT, W. C., RASKIND, M. & SCHELLENBERG, G. D. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Annals of Neurology 43, 815–825.
PROBST, A., GOTZ, J., WIEDERHOLD, K. H., TOLNAY, M., MISTI, C., JATON, A. L., HONG, M., ISHIHARA, T., LEE, V. M.-Y., TROJANOWSKI, J. Q., JAKES, R., CROWTHER, R. A., SPILLANTINI, M. G., BURKI, K. & GOEDERT, M. (2000) Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathologica 99, 469–481.
RIZZU, P., VAN SWIETEN, J. C., JOOSSE, M., HASEGAWA, M., STEVENS, M., TIBBEN, A., NIERMEIJER, M. F., HILLEBRAND, M., RAVID, R., OOSTRA, B. A., GOEDERT, M., VAN DUIJN, C. M. & HEUTINK, P. (1999) High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. American Journal of Human Genetics 64, 414–421.
ROOS, R. A. C. & BOTS, G. TH. A. M. (1983) Nuclear membrane indentations in Huntington's chorea. Journal of the Neurological Sciences 61, 37–47.
ROOS, R. A. C., BOTS, G. TH. A. M. & HERMANS, J. (1985) Neuronal nuclear membrane indentation and astrocyte/ neuron ratio in Huntington's disease. A quantitative electron microscopic study. Journal fur Hirnforschung 26, 689–693.
SAHARA, N., LEWIS, J., DETURE, M., MCGOWAN, E., DICKSON, D. W., HUTTON, M. & YEN, S.-H. (2002) Assembly of tau in transgenic animals expressing P301L tau: Alteration of phosphorylation and solubility. Journal of Neurochemistry 83, 1498–1508.
SEITELBERGER, F. (1986) Neuroaxonal dystrophy: its relation to aging and neurological diseases. In Handbook of Clinical Neurology, vol. 5, Exptrapyramidal Disorders. (edited by VINKEN, P. J., BRUYN, G.W. & KLAWANS, H. L.) pp. 391P–415 Amsterdam: Elsevier.
SIMA, A. A. F., DEFENDINI, R., KEOHANE, C., D'AMATO, C., FOSTER, N. L., PARCHI, P., GAMBETTI, P., LYNCH, T. & WILHELMSEN, K. C. (1996) The neuropathology of chromosome 17-linked dementia. Annals of Neurology 39, 734–743.
SPILLANTINI, M. G., MURRELL, J. R., GOEDERT, M., FARLOW, M. R., KLUG, A. & GHETTI, B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proceedings of the National Academy of Science USA 95, 7737–7741.
SPITTAEL, K., VAN DEN HAUTE, C., VAN DORPE, J., BRUYNSEELS, K., VANDEZANDE, K., LAENEN, I., GEERTS, H., MERCKEN, M., SCIOT, R., VAN LOMMEL, A., LOOS, R. & VAN LEUVEN, F. (1999) Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. American Journal of Pathology 155, 2153–2165.
STAMER, K., VOGEL, R., THIES, E., MANDELKOW, E. & MANDELKOW, E.-W. (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. Journal of Cell Biology 156, 1051–1063.
TANEMURA, K., MURAYAMA, M., AKAGI, T., HASHIKAWA, T., TIMINAGA, T., ICHIKAWA, M., YAMAGUCHI, H. & TAKASHIMA, A. (2002) Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. Journal of Neuroscience 22, 133–141.
TERRY, R. D., GONATAS, N. K. & WEISS, M. (1964) Ultrastructural studies in Alzheimer's presenile dementia. American Journal of Pathology 44, 269–297.
WEAVER, C. L., ESPINOZA, M., KRESS, Y. & DAVIES, P. (2000) Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiology of Aging 21, 719–727.
ZHOU, L., MILLER, B. L., MCDANIEL, C. H., KELLY, L., KIM, O. J. & MILLER, C. A. (1998) Frontotemporal dementia: Neuropil spheroids and presynaptic terminal degeneration. Annals of Neurology 44, 99–109.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lin, WL., Lewis, J., Yen, SH. et al. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau. J Neurocytol 32, 1091–1105 (2003). https://doi.org/10.1023/B:NEUR.0000021904.61387.95
Issue Date:
DOI: https://doi.org/10.1023/B:NEUR.0000021904.61387.95